Gumusay, Ö. Et Al. 2020. Pazopanib (PZ) plus endocrine therapy as treatment for hormone resistant advanced breast cancer (ABC).. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , (ELECTR NETWORK).

Gumusay, Ö., Majure, M. C., Deal, T., Renslo, J. R., Wabl, C. A., Melisko, M. E., ... Chien, A. J.(2020). Pazopanib (PZ) plus endocrine therapy as treatment for hormone resistant advanced breast cancer (ABC). . Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK

Gumusay, ÖZGE Et Al. "Pazopanib (PZ) plus endocrine therapy as treatment for hormone resistant advanced breast cancer (ABC).," Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 2020

Gumusay, ÖZGE Et Al. "Pazopanib (PZ) plus endocrine therapy as treatment for hormone resistant advanced breast cancer (ABC).." Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , ELECTR NETWORK, 2020

Gumusay, Ö. Et Al. (2020) . "Pazopanib (PZ) plus endocrine therapy as treatment for hormone resistant advanced breast cancer (ABC).." Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , ELECTR NETWORK.

@conferencepaper{conferencepaper, author={ÖZGE GÜMÜŞAY Et Al. }, title={Pazopanib (PZ) plus endocrine therapy as treatment for hormone resistant advanced breast cancer (ABC).}, congress name={Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)}, city={}, country={ELECTR NETWORK}, year={2020}}